<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04362020</url>
  </required_header>
  <id_info>
    <org_study_id>RAPID-2</org_study_id>
    <nct_id>NCT04362020</nct_id>
  </id_info>
  <brief_title>Strategies to Maintain Radial Artery Patency Following Diagnostic Coronary Angiography - Subgroup of Patients on Oral Anticoagulants</brief_title>
  <acronym>RAPID-2</acronym>
  <official_title>Strategies to Maintain Radial Artery Patency Following Diagnostic Coronary Angiography - Subgroup of Patients on Oral Anticoagulants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Luebeck</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Luebeck</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate whether omitting systemic anticoagulation during transradial coronary
      angiography and/or a distal radial access reduce the risk of postprocedural radial artery
      occlusion
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2020</start_date>
  <completion_date type="Anticipated">August 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of postprocedural radial artery occlusion</measure>
    <time_frame>Day 1</time_frame>
    <description>Will be the occurrence of postprocedural radial artery occlusion assessed with high-resolution vascular ultrasound. Experienced sonographers will perform color Doppler ultrasound in all study patients after removal of the compression device to examine the radial, ulnar, and brachial arteries of the access forearm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sonographic characteristics of radial artery occlusion</measure>
    <time_frame>3 Month</time_frame>
    <description>Occlusion lengths or minimal residual perfusion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Patient Undergoing Diagnostic Coronary Angiography</condition>
  <arm_group>
    <arm_group_label>Group-1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No anticoagulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group-2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ACT-guided anticoagulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Distal radial access</intervention_name>
    <description>Distal radial access and No anticoagulation</description>
    <arm_group_label>Group-1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Distal radial access</intervention_name>
    <description>Distal radial access and ACT-guided anticoagulation</description>
    <arm_group_label>Group-2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical indication to perform diagnostic coronary angiography

          -  Pretreatment with oral anticoagulants (phenprocoumon or direct oral anticoagulants
             [dabigatran, apixaban, rivaroxaban, or edoxaban])

          -  Age &gt; 18 years

          -  Written informed consent

        Exclusion Criteria:

          -  Already administered additional anticoagulation prior to coronary angiography

          -  Planned coronary intervention

          -  Preexisting radial artery occlusion or missing pulse at the potential puncture sites

          -  Allergy / intolerance to anticoagulants

          -  Active bleeding or comorbidity with elevated bleeding risk

          -  Pregnancy

          -  Inability to sign informed consent

          -  Participation in another trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 22, 2020</study_first_submitted>
  <study_first_submitted_qc>April 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2020</study_first_posted>
  <last_update_submitted>May 8, 2020</last_update_submitted>
  <last_update_submitted_qc>May 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Luebeck</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. Ingo Eitel</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

